Sachi Nishino, None;
Tsutomu Yasukawa, Alcon Japan (R), Alcon Pharma (F), Alcon Pharma (R), AMO Japan (R), Baseconnect Inc. (R), Bausch & Lomb Japan (R), Bayer (R), CRESCO (R), HOYA (F), HOYA (R), NIDEK (F), NIKKEN SOHONSHA (R), Nitten (R), Novartis Pharma (R), ONO PHARMACEUTICAL (R), Pfizer (R), Santen (R), SANWA KAGAKU KENKYUSHO (R), Senju (R);
Hiroko Imaizumi, None;
Hisashi Mastubara, Bayer (R), Novartis Pharma (F), Novartis Pharma (R), Santen (R), Senju (R);
Hiroto Ishikawa, Alcon (F), AMO (R), Santen (R);
Kazuhiro Kimura, Bayer (R), Novartis Pharma (R), Pfizer (R), Santen (R);
Hiroto Terasaki, Alcon Pharma (F), Alcon Pharma (R), Bayer (R), JFC Sales Plan (R), Santen (R);
Yoshinori Mitamura, Alcon Japan (F), AMO Japan (F), Pfizer (F), Santen (F);
Toshinori Murata, Alcon Pharma (F), Bayer (F);
Mariko Yamashita, None;
Jiro Kogo, None;
Masaru Takeuchi, None;
Yoshihiro Takamura, None;
Tomoya Murakami, None;
Taiji Sakamoto, Alcon Japan (R), Alcon Japan (F), Bayer (R), Bayer (F), Graybug (R), Novartis Pharma (R), Novartis Pharma (F), Novartis Pharma (C), Santen (R), Santen (F), Santen (C), Senju (R), Senju (F), Senju (C), TOPCON (P);
Masahito Ohji, Alcon Japan (F), Alcon Japan (R), Allergan (C), Baseconnect Inc. (R), Bayer (R), Bayer (C), HOYA (F), HOYA (C), Kowa (R), Novartis Pharma (F), Novartis Pharma (R), Novartis Pharma (C), Otsuka Pharmaceutical Co. (F), Otsuka Pharmaceutical Co. (R), Pfizer (F), Pfizer (R), R.E.MEDICAL (R), Santen (F), Santen (R), Santen (C), Senju (F), Senju (R), TOPCON (R), ZEISS (R)